Estimating long-term mortality in women with hormone receptor-positive breast cancer: The ‘ESTIMATE’ tool-Reference-Cited by-同舟云学术

Estimating long-term mortality in women with hormone receptor-positive breast cancer: The ‘ESTIMATE’ tool

Published:2022-09 Issue: Volume:173 Page:20-29
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Leone José P.,Graham Noah,Tolaney Sara M.,Leone Bernardo A.,Freedman Rachel A.,Hassett Michael J.^ORCID,Leone Julieta,Vallejo Carlos T.^ORCID,Winer Eric P.,Lin Nancy U.,Tayob Nabihah

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference20 articles.

1. 20-Year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years;Pan;N Engl J Med,2017

2. PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer;Wishart;Breast Cancer Res,2010

3. The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients;Dubsky;Br J Cancer,2013

4. Breast cancer index identifies early-stage estrogen receptor-positive breast cancer patients at risk for early- and late-distant recurrence;Zhang;Clin Cancer Res,2013

5. Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population;Sgroi;Lancet Oncol,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer;JAMA Oncology;2024-04-01

2. Prognostic Nomograms for Patients with Primary Sarcomatoid Carcinoma of The Urinary Bladder: Based on The SEER Database;UROL J;2024

3. Estimating mortality in women with triple-negative breast cancer: The ‘ESTIMATE triple-negative’ tool;European Journal of Cancer;2023-08

4. Clinical outcomes of adjuvant taxane plus anthracycline versus taxane-based chemotherapy regimens in older adults with node-positive, triple-negative breast cancer: A SEER–Medicare study;European Journal of Cancer;2023-05

5. Adjuvant Chemotherapy in Older Women With Early Breast Cancer;Journal of Clinical Oncology;2023-03-20